EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Medication non-adherence: reflecting on two decades since WHO adherence report and setting goals for the next twenty years

Przemyslaw Kardas, Bryan Bennett, Bijan Borah, Michel Burnier, Christopher Daly, Mickael Hiligsmann, Enrica Menditto, Andrew M Peterson, Julia F Slejko, Krisztina Tóth, Elizabeth Unni, Tamás Ágh

Frontiers in Pharmacology · 23.12.2024 · 15

DOI: 10.3389/fphar.2024.1444012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 23.12.2024. Verfasst von Przemyslaw Kardas und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medication Adherence Research Center, Department of Family Medicine, Medical University of Lodz, Lodz, Poland. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non-adherence to medication remains a persistent and significant challenge, with profound implications for patient outcomes and the long-term sustainability of healthcare systems. Two decades ago, the World Health Organization (WHO) dedicated its seminal report to adherence to long-term therapies, catalysing notable changes that advanced both research and practice in medication adherence. The aim of this paper was to identify the most important progress made over the last 2 decades in medication adherence management and to initiate a discussion on future objectives, suggesting priority targets for the next 20 years.

Methods

This research used the WHO adherence model as a theoretical framework, categorizing adherence factors into five dimensions: health system, therapy, condition, patient-related, and socioeconomic. Ten international experts, five from Europe and five from the United States, were assigned to these dimensions and participated in structured online discussions. Initially, based on their desk reviews, experts identified significant achievements and future targets. They then ranked these items and provided feedback through several rounds, ensuring anonymity to minimize bias, ultimately reaching a consensus. This iterative process allowed for the creation of top-ten lists of past achievements and future targets for medication adherence management over the next 20 years.

Results

Analysis of the top-ranked achievements affirms that notable progress has been made in medication adherence research and practice over the past 20 years, with increased awareness and a surge in dedicated scientific publications. Despite these advancements, non-adherence remains a prevalent issue, underscoring the need for the ongoing implementation of innovative solutions identified in this work, such as novel digital health solutions. Interdisciplinary collaboration and a holistic understanding of patient behaviours and socio-economic factors are crucial.

Conclusion

While refraining from imposing a rigid “adherence Decalogue,” we are confident that this overview of recent achievements and the curated selection of future targets may provide a useful foundation for further discussions aimed at advancing medication adherence management. Our results call for a paradigm shift, advocating the repositioning of medication adherence on national agendas and underscoring the necessity for an adherence-supportive ecosystem that extends beyond mere patient support.

Schlagwörter

Stichwörter der Autor:innen

digital health technologiesdrug therapyhealthcare costsinnovationmedication adherencepatient educationpatient outcomespolypharmacy

Autor:innen und Institutionen

  • Medication Adherence Research Center, Department of Family Medicine, Medical University of Lodz, Lodz, Poland.
  • Patient Centred Outcomes, Jazz Pharmaceuticals, Oxford, United Kingdom.
  • Division of Healthcare Delivery Research, Mayo Clinic College of Medicine and Science and the Kern Center for the Science of Healthcare Delivery, Mayo Clinic, Rochester, MN, United States.
  • Faculty of Biology and Medicine, Switzerland and Hypertension Research Foundation, University of Lausanne, Lausanne, Switzerland.
  • Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY, United States.
  • Department of Health Services Research, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, Netherlands.

Zitieren

APA

Kardas, P., Bennett, B., Borah, B., Burnier, M., Daly, C., Hiligsmann, M., Menditto, E., Peterson, A. M., Slejko, J. F., Tóth, K., Unni, E., & Ágh, T. (2024). Medication non-adherence: reflecting on two decades since WHO adherence report and setting goals for the next twenty years. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1444012

Vancouver

Kardas P, Bennett B, Borah B, Burnier M, Daly C, Hiligsmann M, et al. Medication non-adherence: reflecting on two decades since WHO adherence report and setting goals for the next twenty years. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1444012

BibTeX
@article{Kardas2024,
  author = {Kardas, Przemyslaw and Bennett, Bryan and Borah, Bijan and Burnier, Michel and Daly, Christopher and Hiligsmann, Mickael and Menditto, Enrica and Peterson, Andrew M and Slejko, Julia F and Tóth, Krisztina and Unni, Elizabeth and Ágh, Tamás},
  title = {Medication non-adherence: reflecting on two decades since WHO adherence report and setting goals for the next twenty years},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1444012}
}
Kostenlos starten →